Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ceftezole, an α-glucosidase inhibitor [IC50: 2.1 μM; Ki: 0.578 μM].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Ceftezole, an α-glucosidase inhibitor [IC50: 2.1 μM; Ki: 0.578 μM]. |
Targets&IC50 | α-glucosidase:(ki)0.578 μM , α-glucosidase:2.1 μM |
In vivo | In vivo streptozotocin-induced mouse model, blood glucose levels are decreased by 30% 20 min after Ceftezole treatment (10 mg/kg/day). Expression levels of GSK-3, peroxisome proliferator-activated receptor-γ, and uncoupling protein-3 mRNA are also slightly decreased compared to controls following Ceftezole treatment. |
Molecular Weight | 437.52 |
Formula | C16H15N5O4S3 |
Cas No. | 65307-12-2 |
Relative Density. | 1.71g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.